Mangoceuticals, Inc.

NasdaqCM MGRX

Mangoceuticals, Inc. Free Cash Flow Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD -0.30

Mangoceuticals, Inc. Free Cash Flow Per Share is USD -0.30 for the Trailing 12 Months (TTM) ending September 30, 2024. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

NasdaqCM: MGRX

Mangoceuticals, Inc.

CEO	Mr. Jacob D. Cohen
IPO Date	March 21, 2023
Location	United States
Headquarters	15110 North Dallas Parkway
Employees	3
Sector	Health Care
Industries Telehealth Pharmaceuticals

Description

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Key trends

Past 5 years